Biopharmx Corp., of Menlo Park, Calif., priced an underwritten public offering comprising class A units and class B units. The class A units, priced at 35 cents each, consist of one share of common stock and one seven-year warrant to purchase 0.75 of a share of common stock with an exercise price of 35 cents.